热门资讯> 正文
NovaBay Pharmaceuticals收到纽约证券交易所合规通知
2024-04-22 13:43
- NovaBay Pharmaceuticals (NYSE:NBY) received NYSE notice stating that the company is below compliance with listing standards pursuant to stockholders equity.
- The company must submit a plan by May 18, 2024 advising of actions it has taken or will take to regain compliance with the continued listing standards by October 18, 2025 in order to continue its listing on the NYSE American.
- The notice has no immediate effect on the listing or trading of stock, and the stock will continue to trade on the NYSE American.
- The stock price dropped 2.8% on Friday during after hours of trade.
More on NovaBay
- NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report
- Seeking Alpha’s Quant Rating on NovaBay
- Historical earnings data for NovaBay
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
